Ironwood Pharmaceuticals, Inc. IRWD today announced
that the underwriters of its previously announced public offering of Class A
common stock have exercised their option to purchase an additional 787,500
shares at a public offering price of $15.09 per share. As a result, the
Company will issue a total of 6,037,500 shares in the offering and will
receive aggregate net proceeds, after underwriting discounts and commissions
and other estimated offering expenses, of approximately $85.3 million. The
offering is expected to close on February 15, 2012, subject to the
satisfaction of customary closing conditions.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in